CEL Events (Past)
- Launch Event - Risk & Regulation: Regulation and the social meaning of risk
- Ethical performance of business – achievements, aspirations and expectations
- Business reputation - ethics in the downturn
- Expertise in Ethics & Risk Regulation
- Inaugural AstraZeneca Think Tank Debate
- The Governance of Autonomous Systems
- Second Annual Lecture: The Moral Limits of Markets
- Perception and Reality: The Compensation Culture
- Performance vs. Compliance: A Global Leader's Guide to Managing Business Conduct
- Tweeting to Topple Tyranny: Social Media, corporate Social Responsibility & Human Rights
- Shareholder Engagement in the Embedded Business Corporation: Investment Activism, Human Rights and TWAIL Discourse
- Conflicts of Interest: A mere governance challenge or a moral maze?
- Humans vs. Robots: Where are the limits of what an autonomous system should do?
- Between Law and Markets: Is there a Role for Ethics and Culture in Financial Regulation?
- Handling Problem Projects - Accountability mechanisms at international financial institutions and case studies
- CEL Annual Lecture 2012: Media Freedoms & Media Standards
- Lehman Brothers and the Lawyers: (When) Are Lawyers Ethically Responsible for Client Wrongs?
- Workshop on the Financial Sustainability of Banks
- Think Tank with Andrew Bailey
Inaugural AstraZeneca Think Tank Debate
Publication date: Mar 19, 2012 4:50:47 PM
Start:
Jul 1, 2010 12:00:00 AM
End:
Jul 1, 2010 12:00:00 AM
Summary
On Thursday 1 July, the UCL Centre for Ethics & Law
held its inaugural Think Tank debate in conjunction with AstraZeneca.
The Think Tank series involves a selection of real-life case studies on
dilemnas currently facing companies, which lie at the interface between
ethics and regulatory compliance. The debates provide a forum whereby
industry and academic thought leaders, along with current UCL students,
can engage in a challenging exchange of ideas.
The topic of the
first debate, which was led by AstraZeneca’s Global Compliance Policy
Director Paul Woods, was Health Literacy and Provision of Information by
Pharmaceutical Companies on Prescription Medicines. This case study
formed the basis of a stimulating evening's discussion involving
participants from a wide range of backgrounds and perspectives. The
participants in the debate were:
- Paul Anderson, Legal Department, Nestlé UK
- Carrie Bradshaw, PhD student in environmental law, UCL
- Dr Iris Chiu, Senior Lecturer in Laws, UCL
- Dr Jillian Craigie, Research Fellow in Psychiatry and Philosophy, Centre of Medical Ethics, King’s College London
- Sam Eastwood, Partner & Head of Business Ethics and Anti-Corruption, Norton Rose LLP
- Dr Sarah Edwards, Senior Lecturer in Research Ethics and Governance, UCL
- Alex Gough, recent LLB graduate & Centre research assistant, UCL
- Stan Kirby, VP Finance Regulatory Compliance, Shell International Trading
- Dr Marc Moore, Director, UCL Centre for Ethics & Law (debate chair)
- Matthew Nicholson, PhD student in international law, UCL
- Lisa Quelch, recent LLB graduate & Senior Moots Officer, UCL Law Society
- Dr Prince Saprai, Lecturer in Laws, UCL
- Dr Nina Seppala, Lecturer in Mangement Science and Innovation, UCL
- John Smart, Head of Fraud and Investigations, Ernst & Young
- Dr Neema Sofaer, Wellcome Trust Research Fellow, Centre of Medical Ethics, King’s College London
- Simon Webley, Research Director, Institute of Business Ethics
- Richard Wiseman, Chief Ethics & Compliance Officer, Royal Dutch Shell plc
- Professor Jonathan Wolff, Professor of Philosophy, UCL
- Paul Woods, Global Compliance Policy Director, AstraZeneca (debate leader)
Page last modified on 19 mar 12 16:50
